Dergiler / The Anatolian Journal of Cardiology / 2015 / Cilt: 15 - Sayı: 4

Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs (Editorial Comment)

Sayfa
311–312
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

ABASSİ, Z., ARMALY, Z. (2015). Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs (Editorial Comment). The Anatolian Journal of Cardiology, Cilt: 15 - Sayı: 4, 311–312. https://ajindex.com/articles/367266

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, et al
  2. CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006
  3. 5K-13K. [CrossRef] 2. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008
  4. [CrossRef] 3. Maliborski A, Zukowski P, Nowicki G, Boguslawska R. Contrast- induced nephropathy- a review of current literature and guide- lines. Med Sci Monit 2011
  5. RA199-204. [CrossRef] 4. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011
  6. e44-122. [CrossRef] 5. Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011
  7. [CrossRef] 6. Dousa TP. Cyclic-3’,5’-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int 1999
  8. [CrossRef] 7. Archer SL, Michelakis ED. Phosphodiesterase Type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 2009
  9. [CrossRef] 8. Güzeloğlu M, Yalçınkaya F, Atmaca S, Bağrıyanık A, Oktar S, Yüksel O, et al. The beneficial effects of Tadalafil on renal ischemia- reperfusion injury in rats. Urol Int 2011
  10. [CrossRef] 9. Sohotnik R, Nativ O, Abbasi A, Awad H, Frajewicki V, Bishara B, et al. Phosphodiesterase-5 inhibition attenuates early renal isch- emia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary NGAL and KIM-1. Am J Physiol Renal Physiol 2013
  11. F1099-104. [CrossRef] 10. Patel NN, Lin H, Toth T, Jones C, Ray P, Welsh GI, et al. Phosphodiesterase-5 inhibition prevents post cardiopulmonary bypass acute kidney injury in swine. Ann Thorac Surg 2011
  12. [CrossRef] 11. Özbek K, Ceyhan K, Koç F, Söğüt E, Altunkaş F, Karayakalı M, et al. The protective effect of single dose tadalafil in contrast-induced nephropathy: An experimental study. Anatol J Cardiol 2015
  13. Lauver DA, Carey EG, Bergin IL, Lucchesi BR, Gurm HS. Sildenafil citrate for prophylaxis of nephropathy in an animal model of con- trast-induced acute kidney injury. PLoS One 2